MedTrace Logo

Evaluation of NaproxenSodium and CodeinePhosphate Combination in Osteoarthritis

NCT02501564 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2016-02-25

No results posted yet for this study

Summary

Osteoarthritis (OA) pain treatment has limitations in terms of serious adverse effects and low efficacy. The investigators aimed to evaluate efficacy and safety of naproxen sodium/codeine phosphate combination in these patients.

Conditions

Interventions

DRUG

Naproxen Sodium Codeine

One tablet twice a day

DRUG

Placebo

One tablet twice a day

Sponsors & Collaborators

  • Abdi Ibrahim Ilac San. ve Tic A.S.

    collaborator INDUSTRY

  • Istanbul Medeniyet University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-11-30
Completion
2015-11-30

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02501564 on ClinicalTrials.gov